Vaccine trial soon amid fear of Ebola virus spread to other countries
Currently there are no vaccines available for the Sudan strain of the Ebola virus
Read More
News
Corbevax booster should be a vaccine of choice
Due to faulty clinical trial design, the superiority of Corbevax heterologous booster over homologous boosters is not known On January
Read More
Walking a tightrope in messaging monkeypox virus transmission routes
Public health communication about different routes of transmission of monkeypox virus is critical, especially as demographics can change
Read More
Time for vigilance as India detects monkeypox cases
Increased testing and building awareness, not stigmatising the infected, can stop the spread of monkeypox
Read More
What is causing a surge in COVID-19 cases in India?
In addition to BA.4 and BA.5, India and about half-a-dozen other countries have reported BA.2.75, which is a new sub-lineage of Omicron
Read More
Study finds three asymptomatic monkeypox cases
The monkeypox viral loads were similar immaterial of whether people showed symptoms or not
Read More
What drives sustained growth of monkeypox cases
Sustained transmission of monkeypox in heterosexual population is unlikely in all scenarios studied by researchers
Read More
Is monkeypox a sexually transmitted infection?
A study found monkeypox virus in the seminal fluid of four men who had sex with men
Read More
Mistake of ignoring monkeypox outbreak in Nigeria
There are no clear answers to how humans are infected as the host animal has not been identified
Read More
Why pangolins may not be the intermediate host for SARS-CoV-2 virus
Pangolin coronavirus produced moderate disease in hamsters and was less virulent
Read More
COVID-19 booster dose may not alter disease severity trend
A cross-sectional survey of nearly 6,000 people across age groups including those over 80 years of age carried out through
Read More
COVID-19 immunity following infection lasts up to 19 months
Hybrid immunity after one and two doses of vaccine was associated with 94% and 90% lower risk of hospitalisation, respectively
Read More
Variants do not always evolve to become less virulent
Since transmission begins before symptoms set in and the disease becomes severe, its characteristic is decoupled from disease
Read More